Home > Journals > Minerva Chirurgica > Past Issues > Minerva Chirurgica 2002 December;57(6) > Minerva Chirurgica 2002 December;57(6):837-45

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CHIRURGICA

A Journal on Surgery


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,115


eTOC

 

REVIEWS  ESOPHAGEAL CANCER


Minerva Chirurgica 2002 December;57(6):837-45

Copyright © 2002 EDIZIONI MINERVA MEDICA

language: English

Role of FDG-PET scan in staging of cancer of the esophagus and gastroesophageal junction

Lerut T., Flamen P.


PDF  


Background. FDG-PET scan has generated in recent years an increasing interest in staging and assessment of response to treatment in cancer patients.
Methods. From the available literature and own data it appears that FDG-PET scan significantly improves detection of haematogenous and distant lymphatic metastasis in carcinoma of the oesophagus and gastro-oesophageal junction (GEJ). Especially diagnostic specificity of lymph node involvement is greatly improved with FDG-PET scan. FDG-PET scan also allows a highly sensitive diagnosis of recurrent disease through its capacity of whole-body staging. In assessing response of induction (chemo ± radiotherapy) in locally advanced disease FDG-PET scan appears to be of high value in predicting response.
Results. Moreover, there seems to be a strong correlation between FDG-PET scan response and survival.
Conclusions. It can be concluded that despite the cost, FDG-PET scan should have a place in the algorithm of initial staging, staging of recurrent disease and assessment of response to treatment in cancer of the oesophagus and GE junction.

top of page

Publication History

Cite this article as

Corresponding author e-mail